Investor Relations Forum – Investor Relations Forum

Having a good product today isn’t enough to attract investment opportunities; you must have the ability to demonstrate a market for the product you are developing. IR departments deliver a channel through which the investment community can effortlessly access information about the company. This is particularly important for information transparency and for promoting a sense of integrity and trustworthiness on the part of the company.

The Investor Relations Forum, taking place on September 7-8, 2017 in Boston, will bring together IR professionals to address the diverse set of challenges faced in the life sciences industry. Our expert speaking faculty will provide thought-provoking dialogue paired with networking opportunities that no other conferences address. IR teams are continuously balancing new regulations, advancements in technology, more engaged investors and working relationships with advisory boards. Through this event IR specialists will be able to efficiently gain the knowledge they need to improve their programs while developing a new network of educated IR colleagues. At this breakthrough two-day conference we will provide our attendees with the solutions to the unique set of challenges IR teams encounter and enable them to be more effective in their jobs.

Top Five Reasons to Attend

  1. Learn crisis communication specific to the life sciences industry
  2. Understand the best methods for dealing with the trials and distresses of an activist shareholder
  3. Address investor relation’s involvement in successful mergers and acquisitions
  4. Tackle the power of social media in 2017 and how it drives stock
  5. Examine the different interests of numerous shareholders that are geographically dispersed

Who Should Attend

  • Investor Relations
  • Public Relations
  • Communications
  • Media Relations
  • Investment Research
  • Corporate Investments
  • Stakeholder Relations
  • Investment Responsibility
  • Compliance

This event is also of interest to:

  • Consulting Firms
  • Financial Services
  • Proxy Solicitation and Corporate Advisory Firms
  • IR Research
  • Corporate Access Platform Providers